| Line Item | 2025-12-31 | Q/Q | Y/Y |
|---|---|---|---|
| Revenue | $185.1M | +9.8% | +9.8% |
| Cost of Revenue | $18.7M | +13.9% | +31.9% |
| Gross Profit | $166.4M | +9.4% | +7.7% |
| R&D Expense | $34.6M | +14.5% | +54.3% |
| SG&A Expense | $17.7M | -7.3% | +30.0% |
| Operating Income | $71.9M | +12.9% | -10.0% |
| Pre-tax Income | $80.8M | +10.8% | -10.1% |
| Income Tax | $19.2M | +76.8% | +31.4% |
| Net Income | $61.6M | -0.8% | -18.1% |
| EPS (Basic) | $0.33 | +0.0% | -17.5% |
| EPS (Diluted) | $0.31 | +0.0% | -16.2% |
| Line Item | 2025-12-31 | Q/Q | Y/Y |
|---|---|---|---|
| Cash & Equivalents | $64.8M | -61.7% | -60.8% |
| Accounts Receivable | $156.6M | +21.1% | +13.9% |
| Current Assets | $993.5M | -9.0% | -1.9% |
| Total Assets | $1.16B | -8.0% | -1.3% |
| Current Liabilities | $149.8M | +6.8% | +29.3% |
| Total Liabilities | $177.7M |
| Line Item | 2025-12-31 | Q/Q | Y/Y |
|---|---|---|---|
| Operating Cash Flow | $216.9M | — | — |
| Investing Cash Flow | $9.2M | — | — |
| Financing Cash Flow | -$370.9M | — | — |
| +26.0% |
| Stockholders' Equity | $979.3M | -10.6% | -5.0% |